32 related articles for article (PubMed ID: 11915576)
1. A systematic review of psychosocial functioning changes after gender-affirming hormone therapy among transgender people.
Doyle DM; Lewis TOG; Barreto M
Nat Hum Behav; 2023 Aug; 7(8):1320-1331. PubMed ID: 37217739
[TBL] [Abstract][Full Text] [Related]
2. GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health.
Bäckström T; Bixo M; Strömberg J
Curr Psychiatry Rep; 2015 Nov; 17(11):92. PubMed ID: 26396092
[TBL] [Abstract][Full Text] [Related]
3. Neurobiological Underpinnings of the Estrogen - Mood Relationship.
Wharton W; Gleason CE; Olson SR; Carlsson CM; Asthana S
Curr Psychiatry Rev; 2012 Aug; 8(3):247-256. PubMed ID: 23990808
[TBL] [Abstract][Full Text] [Related]
4. Neurosteroids and GABA-A Receptor Function.
Wang M
Front Endocrinol (Lausanne); 2011; 2():44. PubMed ID: 22654809
[TBL] [Abstract][Full Text] [Related]
5. A history of depression in women is associated with an altered GABAergic neuroactive steroid profile.
Girdler SS; Lindgren M; Porcu P; Rubinow DR; Johnson JL; Morrow AL
Psychoneuroendocrinology; 2012 Apr; 37(4):543-53. PubMed ID: 21890277
[TBL] [Abstract][Full Text] [Related]
6. Effects of neurosteroid actions at N-methyl-D-aspartate and GABA A receptors in the midbrain ventral tegmental area for anxiety-like and mating behavior of female rats.
Frye CA; Paris JJ
Psychopharmacology (Berl); 2011 Jan; 213(1):93-103. PubMed ID: 20878318
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute progesterone administration upon responses to acute psychosocial stress in men.
Childs E; Van Dam NT; de Wit H
Exp Clin Psychopharmacol; 2010 Feb; 18(1):78-86. PubMed ID: 20158297
[TBL] [Abstract][Full Text] [Related]
8. Progesterone and medroxyprogesterone acetate differentially regulate alpha4 subunit expression of GABA(A) receptors in the CA1 hippocampus of female rats.
Pazol K; Northcutt KV; Patisaul HB; Wallen K; Wilson ME
Physiol Behav; 2009 Apr; 97(1):58-61. PubMed ID: 19394921
[TBL] [Abstract][Full Text] [Related]
9. Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone.
Andréen L; Sundström-Poromaa I; Bixo M; Nyberg S; Bäckström T
Psychopharmacology (Berl); 2006 Aug; 187(2):209-21. PubMed ID: 16724185
[TBL] [Abstract][Full Text] [Related]
10. Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders.
N-Wihlbäck AC; Sundström-Poromaa I; Bäckström T
Psychopharmacology (Berl); 2006 Jun; 186(3):388-401. PubMed ID: 16362406
[TBL] [Abstract][Full Text] [Related]
11. Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques.
Pazol K; Wilson ME; Wallen K
J Clin Endocrinol Metab; 2004 Jun; 89(6):2998-3006. PubMed ID: 15181090
[TBL] [Abstract][Full Text] [Related]
12. The role of hormones and hormonal treatments in premenstrual syndrome.
Bäckström T; Andreen L; Birzniece V; Björn I; Johansson IM; Nordenstam-Haghjo M; Nyberg S; Sundström-Poromaa I; Wahlström G; Wang M; Zhu D
CNS Drugs; 2003; 17(5):325-42. PubMed ID: 12665391
[TBL] [Abstract][Full Text] [Related]
13. Adverse mood effects during postmenopausal hormone treatment in relation to personality traits.
Björn I; Bäckström T; Lalos A; Sundström-Poromaa I
Climacteric; 2006 Aug; 9(4):290-7. PubMed ID: 16857659
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
Mattsson LA; Skouby S; Rees M; Heikkinen J; Kudela M; Stadnicki-Kolendo A; Mattila L; Salminen K; Vuorela A; Mustonen M;
Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
[TBL] [Abstract][Full Text] [Related]
15. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy.
Björn I; Sundström-Poromaa I; Bixo M; Nyberg S; Bäckström G; Bäckström T
J Clin Endocrinol Metab; 2003 May; 88(5):2026-30. PubMed ID: 12727949
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy in postmenopausal women.
Yasui T; Uemura H; Takikawa M; Irahara M
J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
[TBL] [Abstract][Full Text] [Related]
17. Added benefits of drospirenone for compliance.
Foidart JM
Climacteric; 2005 Oct; 8 Suppl 3():28-34. PubMed ID: 16203653
[TBL] [Abstract][Full Text] [Related]
18. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy.
Björn I; Bixo M; Nöjd KS; Collberg P; Nyberg S; Sundström-Poromaa I; Bäckström T
Gynecol Endocrinol; 2002 Feb; 16(1):1-8. PubMed ID: 11915576
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
